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Neutral ceramidase (nCDase) catalyzes conversion
of the apoptosis-associated lipid ceramide to
sphingosine, the precursor for the proliferative fac-
tor sphingosine-1-phosphate. As an enzyme regu-
lating the balance of ceramide and sphingosine-1-
phosphate, nCDase is emerging as a therapeutic
target for cancer. Here, we present the 2.6-A˚ crystal
structure of human nCDase in complex with phos-
phate that reveals a striking, 20-A˚ deep, hydro-
phobic active site pocket stabilized by a eukary-
otic-specific subdomain not present in bacterial
ceramidases. Utilizing flexible ligand docking, we
predict a likely binding mode for ceramide that
superimposes closely with the crystallographically
observed transition state analog phosphate. Our
results suggest that nCDase uses a new catalytic
strategy for Zn2+-dependent amidases, and gener-
ates ceramide specificity by sterically excluding
sphingolipids with bulky headgroups and specif-
ically recognizing the small hydroxyl head group
of ceramide. Together, these data provide a foun-
dation to aid drug development and establish
common themes for how proteins recognize the
bioactive lipid ceramide.
INTRODUCTION
Sphingolipids are a family of membrane lipids that play impor-
tant roles in transducing cellular signaling processes (Hannun
and Obeid, 2008). They can have a wide range of functional
effects including promoting migration, cell proliferation, sene-
scence, and apoptosis (Hannun and Obeid, 2008; Morad and
Cabot, 2012; Ogretmen and Hannun, 2004; Spiegel and
Milstien, 2003). Ceramide, sphingosine (Sph), and sphingo-
sine-1-phosphate (S1P) are three of the most extensively
studied bioactive sphingolipid species (Futerman and Hannun,
2004; Hannun and Obeid, 2008). Ceramide lies at the center
of sphingolipid metabolism and serves as a central hub for1482 Structure 23, 1482–1491, August 4, 2015 ª2015 Elsevier Ltd Alinterconversion between sphingolipids (Airola and Hannun,
2013). Several enzymes control the levels and turnover of
ceramide, and many of these ceramide-metabolizing enzymes
have been proposed as candidate therapeutic targets in
various conditions (Canals et al., 2011; Garcı´a-Barros et al.,
2013; Saied and Arenz, 2013). Moreover, their combined
substrate specificities define the ceramide-centric metabolism
of sphingolipids (Gault et al., 2010; Hannun and Obeid,
2002). However, the mechanisms by which these enzymes
generate their specificity are unclear due to a lack of struc-
tural information.
Ceramidases (CDases) are lipid amidases that catalyze the hy-
drolysis of the amide bond of ceramide to form Sph and a fatty
acid (Figure 1A) (Mao and Obeid, 2008). CDases occupy a key
role in sphingolipid metabolism by converting the apoptosis-
associated lipid ceramide to Sph, a precursor for the proliferative
factor S1P (Futerman and Hannun, 2004; Mao and Obeid, 2008).
Three families of CDases (acid, neutral, and alkaline) have been
identified that are distinguished by their pH optima, subcellular
localization, primary structure, mechanism, and function (Mao
and Obeid, 2008).
Neutral ceramidase (nCDase) is a single-pass transmem-
brane glycoprotein (El Bawab et al., 2000; Tani et al., 2000)
that is highly expressed in the intestinal system and localizes
to the brush border of intestinal and colonic epithelial cells
(Kono et al., 2006). NCDase knockout mice are viable, but
display altered intestinal sphingolipid levels and increased
levels of ceramide in stool samples (Kono et al., 2006). The
expression and activity of nCDase has been linked to cell-cy-
cle arrest and growth regulation (Franzen et al., 2001; Osawa
et al., 2005; Wu et al., 2009), which has established nCDase
as an attractive target for pharmacological interventions
(Canals et al., 2011; Saied and Arenz, 2013). An alternative
form of nCDase with an altered N terminus localizes to mito-
chondria (El Bawab et al., 2000) and has been implicated
in the pathogenesis of traumatic brain injury (Novgorodov
et al., 2014).
Human nCDase is a novel enzyme that defines a unique family
of evolutionarily conserved CDases, which display little seq-
uence homology to other proteins including acid and alkaline
CDases (Mao and Obeid, 2008). NCDase displays strict sub-
strate specificity for the endogenous stereoisomer of ceramide
(El Bawab et al., 2002; Usta et al., 2001). Sphingolipids withl rights reserved
Figure 1. Characterization of Purified Hu-
man nCDase
(A) Neutral ceramidase hydrolyzes the amide bond
of ceramide to generate sphingosine and free fatty
acid.
(B) Initial velocity (mM/min) versus substrate con-
centration (mM) of purified human nCDase activity
toward NBD-C12-ceramide. Km and kcat values
are indicated. Reactionswere conductedwith 5 ng
of purified nCDase at 28C for multiple time points
between 15 min and 2 hr.
Data are shown as means ± SEM from three in-
dependent experiments.
See also Figure S1.modifications to the 1-hydroxyl head group of ceramide do not
act as substrates. Thus, nCDase specifically hydrolyzes the
amide bond of ceramide and not ceramide-1-phosphate (C1P),
sphingomyelin, or glycosphingolipids (Figure S1).
Bacterial nCDases from Pseudomonas aeruginosa and
Mycobacterium tuberculosis have been cloned and implicated
as exotoxins in these pathogens (Okino et al., 1999; Okino
and Ito, 2007). Structural characterization of the bacterial
nCDase (bCDase) from P. aeruginosa revealed a shallow
active site cleft for ceramide hydrolysis (Inoue et al., 2009).
Bacterial CDase was proposed to follow a catalytic mecha-
nism similar to that of Zn2+-dependent carboxypeptidase.
However, this mechanism did not account for the unique
tetra-coordinated Zn2+ ion and involved only one of the four
strictly conserved active site residues. Furthermore, while
bCDase shares some overall sequence identity with human
nCDase (37%), the amino acid sequence and length of key
regions that form the active site differ, which suggests that
human nCDase may contain a unique active site pocket.
This led us to structurally characterize human nCDase to
gain insights into the molecular mechanism of this emerging
therapeutic target.
Here, we draw on structural, computational, and biochem-
ical data to show that human nCDase is indeed a novel lipid
amidase that contains a deep hydrophobic active site pocket
for ceramide binding and hydrolysis. Based on active site in-
teractions with the crystallographically observed transition
state analog phosphate and flexible ligand docking of cer-
amide, we suggest nCDase employs a unique catalytic mech-
anism that involves stabilizing the transition state oxyanion
through protein side-chain interactions and not by direct
Zn coordination. This differs from the proposed mechanisms
of other Zn-dependent amidases, including bCDase (Finnin
et al., 1999; Hernick and Fierke, 2005). Furthermore, our re-
sults shed light on how nCDase generates its strict substrate
specificity toward ceramide. We propose nCDase uses the
deep hydrophobic pocket that ends abruptly at the catalytic
Zn2+ ion to (1) sterically exclude sphingolipids with larger
headgroups and (2) facilitate specific recognition of the small
hydroxyl head group of ceramide. This represents the first
structural characterization of a eukaryotic ceramide-metabo-
lizing enzyme, and a new molecular perspective in the function
of this diverse set of proteins.Structure 23, 1482RESULTS
Purification of Active, Glycosylated Human nCDase
An extracellular region of human nCDase (residues 99–780,
lacking the flexible O-glycosylated mucin box) was overex-
pressed in Sf9 cells as a secreted protein, purified by Ni-column
and size-exclusion chromatography, and crystallized (Figure S2).
The purified protein was active toward the fluorescent substrate
NBD-C12-ceramide (Tani et al., 1999) with a Km of 33 mM and
a turnover number (kcat) of 62 min
1 at 28C (Figure 1B). N-
Glycosylation of nCDase was confirmed by PNGaseF treatment
(Figure S2C).
Overall Architecture
We determined the crystal structure of the N-glycosylated extra-
cellular region of human nCDase in complex with phosphate at
2.6 A˚ resolution (Table 1). Two protein molecules were contained
within the asymmetric unit that superimposed with a root-mean-
square deviation (RMSD) of 0.24 A˚. The structure consists of
a catalytic domain (residues 99–626), a short linker (627–641),
and an immunoglobulin (Ig)-like domain (642–780) (Figure 2).
Electron density was observed for all residues except the loop
regions between amino acids 637–641, 686–687, and 758–761.
The Ig-like and catalytic domains are bridged by a Ca2+ ion
that is coordinated by protein backbone interactions and the
side chain of Thr717. The base of the catalytic domain is formed
by a novel three-b-sheet triangle (Figure S2) that represents a
unique protein fold, with a Dali search identifying bCDase as
the only similar protein in the PDB. A number of loops and
secondary structural elements sit atop the b-triangle core to
form the active site. Electron density for N-linked glycans was
observed at Asn151, Asn217, Asn308, and Asn440 in the
catalytic domain, and Asn730 in the Ig-like domain (Figure 2B).
Solvent-exposed disulfide bonds were present in the cata-
lytic domain between Cys362–Cys376, Cys370–Cys384, and
Cys448–Cys498, which indicates a likely explanation for the
sensitivity of nCDase activity to reducing agents (Figure 2B) (El
Bawab et al., 1999; Galadari et al., 2006).
A Deep, Hydrophobic Active Site Pocket
The active site of human nCDase is composed of a narrow,
20-A˚ deep, hydrophobic pocket with a Zn2+ ion at the base (Fig-
ure 2C). The entrance to the hydrophobic active site pocket is–1491, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1483
Table 1. Crystallographic Data Collection and Refinement
Statistics
Human nCDase (PDB: 4WGK)
Data Collection
Wavelength (A˚) 0.987
Resolution range (A˚) 68.65–2.582 (2.674–2.582)
Space group P21
Unit cell dimensions
a, b, c (A˚) 73.48, 156.63, 80.33
a, b, g () 90, 108.04, 90
Total reflections 90,770 (8,225)
Unique reflections 49,612 (4,716)
Multiplicity 1.8 (1.7)
Completeness (%) 91.63 (87.4)
Rmerge 0.0805 (0.3726)
<I>/<sI> 7.42 (1.90)
Refinement
Rwork/Rfree 17.8 (25.8)/22.3 (32.3)
No. of atoms
Total 11,142
Protein 10,408
Ligand/ion 240
Water 494
B factors (A˚2)
B factor 31.2
Protein 30.8
Ligand/ion 52.8
Water 29.3
RMSD
Bond lengths (A˚) 0.003
Bond angles () 0.67
Ramachandran favored (%) 98
Ramachandran outliers (%) 0
Values in parentheses are for highest-resolution shell.unobstructed and solvent accessible (Figure 2C), and appears
flexible, with the highest B factors observed in these regions of
the protein. Hydrophobic residues line the pocket from top to
bottom (Figures 2D and 3E). One side of the active site cavity
of human nCDase is formed by the h2-a8 helices, which have
a divergent amino acid sequence (Figure 2G) and are reposi-
tioned in comparison with bCDase (Figure 2B versus Figure 2E;
Figures S3F and S3G). A 30-residue insertion, not present in
bCDase, forms a novel, small disulfide-containing domain that
interacts with the h2-a8 helices to stabilize their position (Fig-
ure 2). An additional stabilizing factor is the third disulfide bridge
in nCDase, which ties together the beginning and end of the h2-
a8 helix element and is conserved between human nCDase and
bCDase (Figure 2B; Figure S4). Overall, the lipid-like contouring
of the active site suggests that either no major rearrangements
are necessary to accommodate ceramide, or that the Zn-bound
phosphate is inducing an active conformation. To initially vali-
date the hydrophobic pocket as the site of ceramide hydrolysis,
we introduced positively charged arginine residues at positions1484 Structure 23, 1482–1491, August 4, 2015 ª2015 Elsevier Ltd AlGly124, Ala211, and Gly465 and determined their effects on
nCDase activity (Figure 4E).
Active Site Architecture and Interactions with the
Transition State Analog Phosphate
A cluster of polar residues lies at the base of pocket that coordi-
nates Zn2+ and interacts with bound phosphate (Figure 3A).
Canonical Zn-dependent amidases have three side chains that
coordinate to the proximal side of Zn2+, and are typically Glu,
Asp, or His residues, with the remaining two Zn-coordination
sites occupied by water molecules (Hernick and Fierke, 2005).
In comparison, human nCDase is unique in that four protein
side chains coordinate the Zn2+ and phosphate occupies the fifth
Zn-coordination site. His194, His303, and Glu540 occupy the
canonical, proximal Zn-coordinating positions, while Tyr579 co-
ordinates to the opposite, distal face of the Zn2+ below phos-
phate (Figure 3B).
Phosphate displays a tetrahedral coordination geometry,
which serves as amimic for the tetrahedral transition state of cer-
amide hydrolysis by nCDase. Analysis of residues in close prox-
imity to phosphate helps to predict the likely interactions with
ceramide during catalysis and provide insight into how nCDase
stabilizes the tetrahedral transition state of hydrolysis. Phos-
phate interacts with three side chains in the active site. His196
is located above the Zn2+ and coordinates to two phosphate ox-
ygen atoms. Tyr579 and Tyr591, which are respectively below
and behind phosphate, coordinate to the same phosphate oxy-
gen atom. The positively charged guanidinium group of Arg257 is
located in the active site and forms a hydrogen bondwith Tyr579.
Together, this suggests that His196, Arg257, Tyr579, and Tyr591
may all play critical roles in catalysis and stabilizing the transition
state of ceramide hydrolysis. Of note, Ser354, previously identi-
fied as important for catalysis (Galadari et al., 2006), is located
at the base of the pocket, 10 A˚ removed from the Zn2+ ion, and
stabilizes the position of Arg257 through a hydrogen bonding
network (Figure 4D).
Flexible Ligand Docking Identifies a Consensus Pose for
Ceramide Binding
To understand the molecular basis for substrate binding and hy-
drolysis, we computationally docked ceramide into the hydro-
phobic active site pocket of nCDase. A rigorous, flexible ligand
docking protocol (Table S1) was employed to impartially dock
ceramide (105 atoms, 34 rotatable bonds, and 2 chiral centers)
into each of the two nCDase protein molecules (chains A and
B) in the asymmetric unit. Approximately 400 unique ceramide
binding poses were generated within each protein chain. Visual
inspection of the top 50 most energetically favorable ceramide
poses revealed a consensus pose that represented both (1) the
single most favorable pose and (2) 50% of the top 50 poses
to both chain A and chain B (Figure 3C). In this consensus
pose, the defining polar regions of ceramide superimposed
with an RMSD of <1.0 A˚ and displayed heterogeneity only after
carbon-11, near the exit of the hydrophobic pocket, where the
lipid tails became solvent exposed (Figure 3F). This model sug-
gests that nCDase must extract ceramide from the membrane
for hydrolysis, and may explain the preference for ceramides of
longer chain length (Mao and Obeid, 2008). In addition, this ex-
plains how the bulky, hydrophilic nitrobenzoxadiazole (NBD)l rights reserved
Figure 2. Crystal Structure of Human nCDase Reveals a Novel, 20-A˚ Deep Hydrophobic Active Site Pocket
(A) Domain organization of human nCDase.
(B) Crystal structure of the catalytic and Ig-like domains of human nCDase (PDB: 4WGK). Catalytic domain, cyan; Ig-like domain, yellow; domain insertion,
orange; h2-a8 helices, magenta. Asn-linked N-glycans are shown as magenta sticks. The Asn151-glycan was only observed in one nCDase molecule and is not
shown. The bound Zn2+ and Ca2+ ions are shown as blue and violet spheres, respectively. Disulfide linkages are shown as sticks.
(C) Surface representation and surface cutaway of human nCDase highlighting the 20-A˚ deep, active site pocket.
(D) Hydrophobic surface representation of human nCDase.
(E) Crystal structure of bacterial nCDase highlighting the differing spatial position and size of the insertion and h2-a8 elements.
(F andG) Sequence alignment of the insertion region (F) and h2-a8 region from human nCDase and bacterial CDase (G), highlighting the divergent sequences that
form the deep hydrophobic pocket in human nCDase. Secondary structure elements are shown above for human nCDase. Connecting lines indicate disulfide
bonds.
See also Figures S2–S4.moiety of the commonly used substrate NBD-C12-ceramide is
accommodated within the active site pocket of nCDase, as it is
predicted to lie just outside the narrowest region of the hydro-
phobic pocket (Figure S1). The highly reproducible computa-
tional predictions are credited to the well-defined active site
pocket of nCDase that appears finely tuned to accommodate
the ceramide lipid (Figures 3E–3G). Superposition with the crys-
tallographic phosphate found that the amide bond of ceramide
was in a near identical position (Figure 3D). This suggested
that the predicted consensus posemight represent the ceramide
binding mode during hydrolysis.
Catalytic Mechanism and Validation
Based on the interactions with phosphate and the predicted
binding pose of ceramide, we propose a general acid-base
catalysis (GABC) mechanism for amide bond hydrolysis by
nCDase (Figure 4A). In this mechanism, the Zn2+ ion functions
to activate a water molecule for nucleophilic attack of the amide
carbon. His196 serves as a general base for proton extraction
from water and, subsequently, a general acid to shuttle this
proton to the nitrogen of ceramide during amide bond cleavage.
In the crystal structure, His196 is the only side chain withinStructure 23, 1482hydrogen bonding distance of two oxygen atoms of phosphate
(Figure 3A), which in our model correspond to the position of
the nucleophilic water and nitrogen atom in the amide bond of
ceramide, and importantly, its proposed role is consistent with
the neutral pH optima of nCDase. Tyr579 and Tyr591, each con-
taining hydroxyl groups that form hydrogen bonds with the
phosphate oxygen atom that faces away from Zn2+ (Figure 3A),
are predicted to polarize the carbonyl group and stabilize the
carbonyl oxyanion formed after nucleophilic attack (Figure 4A).
Consistent with this mechanism, the mutations H196A, Y579F,
and Y591F, as well as mutation of the three proximal Zn-coordi-
nating residues, all abolished nCDase activity (Figure 4E). Addi-
tional substitutions of H196 and Y579 designed to mimic the
proposed functions also completely eliminated enzyme activity
(Figure S5), which is consistent with the strict sequence conser-
vation of the active site core.
One caveat to our proposed mechanism is that the carbonyl
oxygen atom in the predicted ceramide consensus pose oc-
cupies the position of the nucleophilic water molecule. Thus,
the amide bond would need to rotate away from the Zn2+
to accommodate a water molecule and hydrogen bond with
Tyr579 and Tyr591. To confirm this possibility, we redocked–1491, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1485
Figure 3. Active Site Interactions with Phosphate and Ceramide
(A and B) NCDase active site highlighting interactions with phosphate and the
four Zn-coordinating side chains from side (A) and top (B) views. Phosphate,
orange and red sticks.
(C) Dock ranking by energy score of the top 50 ceramide binding poses.
Consensus and non-consensus poses are shown as red and black circles,
respectively. (Inset) Overlay of ceramide consensus poses.
(D) Active site interactions with overlay of phosphate and lowest energy cer-
amide consensus pose in same view as (B).
(E) Cartoon depiction of ceramide in the active site with surrounding hydro-
phobic side chains shown as sticks.
(F and G) Surface representations of ceramide in the active site pocket from
side (F) and top (G) views.
See also Figure S6.ceramide into the active site with a water molecule placed in the
same position as the Zn-coordinating oxygen atom of phos-
phate. Of the 1,000 generated ceramide binding poses, three
distinct consensus conformations were identified that distrib-
uted approximately evenly among the top 150most energetically
favorable poses. While two of these poses were in positions that
would not support hydrolysis, one of the new consensus poses
was similar to the original consensus ceramide pose (Figure S6),
but with the amide bond flipped approximately 180 into a posi-
tion available for hydrolysis (Figure 4B). This suggested that the
proposed binding mode of ceramide in our catalytic mechanism
is both energetically favorable and physically possible. As a final
validation of this mechanism, we docked the transition state1486 Structure 23, 1482–1491, August 4, 2015 ª2015 Elsevier Ltd Alanalog of ceramide (Figure 4A, bottom right panel) with the
amide carbonyl replaced with a tetrahedral carbon center con-
taining an oxyanion and a hydroxyl group. This generated a cer-
amide consensus pose (Figure S6) that superimposed with
phosphate and made identical interactions with the side chains
of His196, Tyr579, and Tyr591 (Figure 4C). Overall, our proposed
mechanism identifies key roles for all the conserved residues in
the active site, and allowed us to predict how nCDase specif-
ically recognizes ceramide and discriminates against other
sphingolipids.
Molecular Determinants of Ceramide Specificity and
Sphingolipid Discrimination
A fundamental question in sphingolipid metabolism is how cer-
amide-metabolizing enzymes generate specificity for ceramide
over other sphingolipid species. This specificity helps direct
the ceramide-centric metabolism of sphingolipids that requires
more complex sphingolipids to first be converted to ceramide
for the amide bond to be hydrolyzed. For example, this prohibits
the direct conversion of C1P, which has a phosphate at the 1-hy-
droxyl head group of ceramide, to S1P.
We used our model to analyze the molecular interactions that
contribute to ceramide recognition and sphingolipid discrimina-
tion in nCDase. In our model, the terminal 1-hydroxyl headgroup
of ceramide hydrogen bonds with the guanidinium group of
Arg257, located at the base of the hydrophobic pocket, adjacent
to the Zn2+ ion (Figure 4D). This suggests that Arg257 is essential
for distinguishing ceramide from other sphingolipids. Consistent
with this prediction, the mutation R257A completely eliminated
nCDase activity (Figure 4E). However, we note that the interac-
tion between Arg257 and Tyr579 also appears critical and may
contribute to the total loss of activity. We also attempted to
alter the substrate specificity of nCDase by mutating Arg257 to
various residues. However, all mutations completely eliminated
nCDase activity toward ceramide (Figure S5A), including the
most conservative substitution R257K; and none of these muta-
tions gained the ability to hydrolyze C1P (Figure S5B).
The specific recognition of the ceramide headgroup by Arg257
indicates that steric hindrance precludes activity toward lipids
with bulkier headgroups, including C1P and 1-O-methyl cer-
amide (El Bawab et al., 2002; Galadari et al., 2006; Usta et al.,
2001). Steric hindrance also provides a simple explanation for
the lack of amidase activity toward sphingomyelin and glyco-
lipids, which respectively contain even larger phosphocholine
and sugar headgroups that cannot be accommodated within
the well-defined active site of nCDase.
The critical position of Arg257 in the active site is stabilized by
a series of hydrogen bonds between surrounding residues (Fig-
ure 4D). These include direct hydrogen bonding interactions with
the side chains of Asp462 and Glu592. Asp462 makes an addi-
tional contact with Ser354. The hydrogen bond network between
Ser354-Asp462-Arg257 provides a rationale for the previous
observation that the S354A mutation inactivates nCDase (Gala-
dari et al., 2006).
An additional substrate-protein interaction was observed be-
tween the side chain of Thr460 and the 3-hydroxyl group of
ceramide (Figure 4D). The mutation T460A significantly reduced,
but did not eliminate, nCDase activity (Figure 4E). Previous
studies found that nCDase could not hydrolyze ceramide withl rights reserved
Figure 4. Catalytic Mechanism and Ceramide Recognition
(A) Proposed catalytic mechanism. Bottom right panel, tetrahedral transition state.
(B) Overlay of ceramide consensus poses with the amide bond rotated for hydrolysis, shown as pink sticks. The water molecule present in the docking cal-
culations is shown as a red sphere.
(C) Side view of docked ceramide transition state, highlighting identical active interactions such as the crystallographically observed transition state analog
phosphate.
(D) Substrate recognition of the hydroxyl head group of ceramide by R257. A network of hydrogen bonds involving the side chains of S354, D462, and E592
stabilizes the position of R257. T460 interacts with the 3-hydroxyl of ceramide. Distances are between the lowest energy ceramide transition state pose.
(E) Activity and expression of nCDase active site mutants. Data are shown as means ± SEM from three to six independent experiments. All mutants behaved
similarly to wild-type nCDase, with no significant changes in yield and no apparent changes in glycosylation status.
See also Figures S5 and S7.a methylated 3-hydroxyl position (El Bawab et al., 2002; Usta
et al., 2001). The predicted hydrogen bonding interaction with
Thr460 is consistent with this finding and helps support the val-
idity of our model.
The Catalytic and Ig-like Domains Are Structurally and
Functionally Linked
Human nCDase contains aC-terminal Ig-like domain of unknown
function that is conserved in the bacterial CDase exotoxins. The
Ig-like and catalytic domains are bridged by a Ca2+ ion that is
coordinated by the side chain of Thr717, four carbonyl groups
from the protein backbone, and a water molecule (Figure 5A).
To ascertain the role of the Ig-like domain, we deleted the entire
region (DIg) and mutated the sole Ca-coordinating side chain
of Thr717 in full-length nCDase. DIg completely lacked nCDase
activity, while the T717A point mutation exhibited significantly
decreased activity (Figure 5B). Structural analysis finds that
the Ca2+ ion and active site are physically linked by a series of
b-sheet type interactions (Figure 5C). We suggest that the Ig-
like domain and Ca2+ binding help to stabilize the tertiary struc-
ture of nCDase and therefore contribute to catalytic activity,
which is consistent with the conservation of the Ig-like domain
in bacterial CDases. We speculate that the Ig-like domain
of human nCDasemay have additional roles inmembrane recog-
nition or protein-protein interactions that will require further
investigation.Structure 23, 1482DISCUSSION
Despite intense research over the past two decades, the struc-
tural basis underlying the ceramide-metabolizing activity of
nCDase and related enzymes has remained elusive. This new
structural information is the first view of how these lipid-metab-
olizing enzymes generate specificity, and provides evidence
that nCDase utilizes a unique mechanism for ceramide hydroly-
sis. As nCDase is an emerging therapeutic target, this may also
aid in drug development.
Model for Ceramide Hydrolysis by nCDase
Human nCDase is highly expressed in the intestinal system and
brain, where ceramide is solubilized in bile acid micelles and
membranes. The deep hydrophobic pocket of human nCDase
differentiates it from its bacterial exotoxin counterparts and pre-
sents a model that human nCDase must at least partially extract
ceramide, depending on the length of the acyl chain (Figure 6).
The highly O-glycosylated mucin box may serve as a flexible
tether that enables nCDase to hydrolyze this bioactive lipid in
these two different physiological forms (Figure 6).
Mechanistic Comparison with Other Zn-Dependent
Amidases
In light of our findings, we propose that nCDase utilizes a
unique catalytic strategy in comparison with other Zn-dependent–1491, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1487
Figure 5. The Catalytic and Immunoglobulin-like Domains Are
Structurally and Functionally Linked
(A) Ca2+ is coordinated between the Ig-like (yellow) and catalytic (cyan) do-
mains by six oxygen atoms from the side chain of Thr717, four carbonyl groups
in the peptide backbone, and a water molecule.
(B) Activity and expression of T717A andDIg nCDasemutants. Data are shown
asmeans ± SEM from three to six independent experiments. EV, empty vector;
WT, wild-type.
(C) The active site loop containing the essential His194 and His196 residues
are linked to the Ca2+ binding site through a series of b-sheet type interactions.amidases (Hernick and Fierke, 2005). The key difference lies in
the occupation of the fourth Zn-coordination site by the hydroxyl
group of Tyr579, which prevents direct coordination and polari-
zation of the amide carbonyl group of ceramide by Zn2+. In
nCDase, we propose that polarization of the amide carbonyl
and stabilization of the transition state oxyanion occurs through
interactions with the protein side chains of Tyr579 and Tyr591,
which both interact with the analogous phosphate oxygen
seen in the nCDase-phosphate complex. To our knowledge, all
other mononuclear Zn-dependent amidases are proposed to
directly coordinate both the hydroxyl group and oxyanion of
the transition state to Zn2+ during catalysis (Hernick and Fierke,
2005). These include the enzymes carboxypeptidase, thermoly-
sin, class I and II histone deacetylases (HDACs), matrix metallo-
proteinases, and LpxC, which, with the exception of HDACs, all
utilize an acidic residue as a general base for GABC (Hernick and
Fierke, 2005). HDACs are the closest mechanistic example to
nCDase, as they use His residues for GABC, and a Tyr residue,
along with Zn coordination, to stabilize the transition state (Finnin
et al., 1999). We did consider the opposite possibility whereby
nCDase uses the Zn2+ ion to polarize the amide carbonyl bond
and the tyrosine residues to activate the water molecule for
nucleophilic attack; however, this mechanism would require a
more complicated proton-shuttling mechanism from Tyr579 to
His196 and thus seems less favorable. In addition, our modeling
of ceramide and the observed interactions with phosphate also
strongly favor our proposed mechanism. We suspect that the
unique mechanism of nCDase may derive from the interaction
of Tyr579 with both the positively charged Zn2+ ion and Arg257
side chain. These interactions may induce a partial positive
charge on the hydroxyl group of Tyr579, and explain how
nCDase polarizes the amide carbonyl bond and stabilizes the
negatively charged oxyanion during catalysis.1488 Structure 23, 1482–1491, August 4, 2015 ª2015 Elsevier Ltd AlThe unique mechanism of human nCDase is likely con-
served by bCDase, given the conservation of key catalytic
residues (Figure S4) and the ability to superimpose the
docked ceramide molecule from the human structure into
the shallow active site cleft of bCDase (Figure S6). The pro-
posed carboxypeptidase-type mechanism for bCDase is
limited by the weakly observed electron density and high B
factors of residues that form the active site pocket (Fig-
ure S3D), and the co-crystallized but non-hydrolyzed sub-
strate C2-ceramide (Figure 7). Our new structural information
from human nCDase in complex with the transition state
analog phosphate provides the necessary new insight to
redefine the catalytic mechanism of this novel lipid amidase.
Importantly, unlike the mechanism proposed for bCDase,
our proposed mechanism identifies clear roles for all the
conserved catalytic residues surrounding the tetra-coordi-
nated Zn2+ ion.
Structural Insight into the Divergent Functions of
Human and Bacterial nCDase
Although human and bacterial nCDase catalyze the same re-
action, their sites for binding ceramide differ drastically due
to inherent differences in the proteins themselves, which re-
flects their divergent functions. As mentioned earlier, human
nCDase functions in the turnover of ceramide within cell mem-
branes and bile acid micelles. Consequently, the human struc-
ture contains a narrow active site pocket that contributes to
the high degree of specificity. In contrast, bacterial nCDase
from P. aeruginosa functions as an exotoxin that rapidly hydro-
lyzes ceramide within cell membranes. As such, the active site
pocket appears to have evolved into an open, shallow cleft
with a high degree of conformational flexibility to enable rapid
ceramide turnover. This conformational flexibility is clearly
visualized by the weak electron density for the h2-a8 helix re-
gion in the bCDase crystal structure and is also indicated by
the associated high-temperature factors (Figure S3). In addi-
tion, the co-crystallized C2-ceramide molecules are also not
well ordered and display quite striking conformational flexibility
(Figure 7), which could indicate problems with the associated
structure or reflect mobility, disorder, or low occupancy of
the C2-ceramide molecules.
General Strategies for Ceramide Recognition
The metabolism of sphingolipids is organized around cer-
amide as a central hub for lipid interconversion, and is
dictated by the strict substrate specificities of the three
subtypes of CDases and the six mammalian ceramide syn-
thases (Gault et al., 2010). This work establishes two related
strategies that nCDase uses to generate specificity toward
ceramide: (1) specific recognition of the 1-hydroxyl headgroup
of ceramide and (2) discrimination of larger headgroups
through steric hindrance. Interestingly, ceramide recognition
by ceramide transfer protein has been demonstrated to utilize
the same two strategies for distinguishing ceramide from other
lipids (Figure S7) (Kudo et al., 2008). This suggests that these
mechanisms may be a conserved feature of ceramide binding
proteins, and it will be important in the future to compare the
approaches utilized by other currently uncharacterized cer-
amide-interacting proteins.l rights reserved
Figure 6. Model of Ceramide Hydrolysis by nCDase in Membranes and Bile Acid Micelles
Schematic of ceramide hydrolysis by the membrane-tethered human nCDase involves extracting ceramide frommembranes (left) or bile acid micelles (right) into
the deep hydrophobic pocket. The flexible tether would allow human nCDase to hydrolyze ceramide in these two different physiological forms. TM, trans-
membrane.Developing nCDase as a Therapeutic Target
nCDase is emerging as a therapeutic target for colon cancer and
traumatic brain injury. This is based on studies using a mouse
model of traumatic brain injury (Novgorodov et al., 2014), find-
ings that nCDase is a target for the action of chemotherapeutics
(Wu et al., 2009), and unpublished data from our group (Hannun
laboratory) identifying nCDase as an important factor in the
carcinogenesis of colon cancer. This work provides key insights
that may aid in developing nCDase as a drug target: (1) it iden-
tifies nCDase as a Zn-dependent amidase and suggests that
hydroxamate-containing compounds may be candidates for
nCDase inhibition (Onishi et al., 1996); (2) the well-defined active
site pocket and successful computational predictions suggest
that in silico docking and virtual screening may be a viable
strategy to identify lead compounds; and (3) the establishment
of a crystallization system will facilitate co-crystal structures
with lead compounds identified using the methods above, or
with the recently generated high-throughput screening strate-
gies now available for human nCDase, for structure activity
refinement (Bedia et al., 2010; Bhabak et al., 2013; Saied and
Arenz, 2013).
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Structure Determination
The extracellular region (residues 99–780) of human nCDase with a C-ter
6xHis-tag and an N-ter insect secretory signal was expressed in Sf9 cells using
baculovirus. Secreted nCDase protein was purified from the media using a
5-ml HisTrap excel column (GE Healthcare) and size-exclusion chromatog-
raphy on a Hi-Load 26-60 Superdex 200 column equilibrated in 100 mM
NaCl and 10mMHEPES (pH 7.0). Pooled nCDase fractions were concentrated
to 3 mg/ml and flash-frozen. Crystals were obtained by hanging-drop vapor
diffusion at 16C by mixing equal volumes nCDase protein and reservoir solu-Structure 23, 1482tion over 0.2MLi2SO4, 10%PEG1000, and 0.1Mcitrate-phosphate buffer (pH
4.6). X-Ray diffraction data were collected at the BNL NSLS X29A beamline on
an ADSC Quantum 315 CCD. Data were processed using XDS (Kabsch, 2010)
and Scala as implemented in the autoPROC pipeline (Vonrhein et al., 2011).
Molecular replacement with P. aeruginosa bCDase (PDB: 2ZWS) was carried
out in PHENIX (Adams et al., 2010). Three rounds of positional and thermal fac-
tor refinement in Coot (Emsley and Cowtan, 2004) and PHENIX (Adams et al.,
2010) resulted in the final structure. During the first refinement the insertion
domain was manually built, after which electron density for the a8 helix
appeared. After the second refinement, electron density for the a2 helix
appeared. Data collection and refinement statistics are provided in Table 1.
Coordinates and structure factors for human nCDase have been deposited un-
der accession code PDB: 4WGK.
Docking Calculations
The ligand C16-ceramide was prepared in MOE (Chemical Computing Group,
2009) and assigned semi-empirical AM1-BCC charges (Jakalian et al., 2000,
2002) using the Amber tool antechamber (Case et al., 2005; Wang et al.,
2006). Chains A and B of nCDase were aligned in a common reference frame
using the matchmaker tool of UCSF Chimera (Pettersen et al., 2004) (aC
RMSD = 0.41 A˚). The metal ions Zn2+ and Ca2+ were retained, and all other
solvent particles were removed. Hydrogen atoms were added with MOE,
and energy minimized using the Amber tool sander for 1,000 cycles with a
1,000.0 kcal mol1 A˚2 restraint on the heavy atoms. Following standard prep-
aration protocols (Brozell et al., 2012; Mukherjee et al., 2010), a surface of each
receptor chain was generated using DMS (2003) and surface spheres were
generated within the proposed binding site (21 spheres in chain A, 17 spheres
in chain B) using sphgen (DesJarlais et al., 1988), then separate boxes with
20-A˚ margins in all directions were generated around the sphere sets. The pro-
gram GRID (Meng et al., 1992) was used to generate a 0.3-A˚ resolution energy
grid within the box boundaries using 6–9 Lennard-Jones coefficients to model
attractive and repulsive van der Waals interactions, respectively, and a dis-
tance-dependent dielectric of ε = 4.0r in the Coulomb potential to model elec-
trostatic interactions. All docking calculations were performed using DOCK 6
(Allen et al., 2015) and standard flexible ligand protocols (Brozell et al., 2012;
Mukherjee et al., 2010), with the exception that the RMSD restraint minimizer–1491, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1489
Figure 7. 2Fo-Fc Electron Density Maps of Human and Bacterial
nCDase Active Sites
2Fo-Fc electron density maps of human and bacterial nCDase active sites
contoured at 1.5 s. The phosphate (human) and water (bacterial) molecules
bound to Zn2+ fit well within the electron density maps. C2-Ceramide (C2-Cer)
electron density (magenta) does not contour around the C2-Cer molecules
(green), which occur in two differing binding modes with the amide bond in a
non-hydrolyzable position in both chains. This may indicate problems with the
associated structure or reflect conformational flexibility from mobility, disor-
der, or low occupancy of the C2-Cer molecules. Figures were generated by
downloading the electron density maps in ccp4 format from the PDB and
visualized in PyMOL.was activated with a restraint of 5.0 kcal mol1 A˚2 on ligand heavy atoms, and
the minimum anchor size oriented to the binding site was three heavy atoms.
Key docking run parameters are provided in Table S1.
Biochemical Assays
Ceramidase activity using the fluorescent substrate NBD-C12-ceramide
(Avanti Polar Lipids) was conducted as described previously, with minor mod-
ifications (Galadari et al., 2006). Full-length nCDase constructs were ex-
pressed in S. cerevisiae cells with the galactose-inducible pYES3 vector.
Amino acid mutations were verified by DNA sequencing. Protein expression
was confirmed bywestern blotting, which found that all mutants behaved simi-
larly to wild-type nCDase, with no significant changes in yield and no apparent
changes in glycosylation status. NCDase activity was quantitated by peak area
comparison of the fluorescent NBD-fatty acid product with standards using an
isocratic high-performance liquid chromatography method in 100% methanol
on a C18:1 Luna column.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, and 3Dmolecular
models and can be found with this article online at http://dx.doi.org/10.1016/j.
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